Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Alopecia areata in Spain has a significant impact with unmet treatment needs and high costs.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

PRP-based treatments can increase hair density, but results vary among individuals.

High-dose IV iron is safe and effective for treating anaemia in IBD patients.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

Finasteride use may increase suicidality risk, especially in young men.

Baricitinib may help people with long-term alopecia areata.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Growth factor concentrate therapy helps manage hair loss.